Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment | MicrobiomeTrials← Back to trialsNCT07171723
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
CompletedEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2025-09-01Est. Completion: 2026-08-12
Enrollment target: 24 participants Locations- Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup, Denmark
Other microbiome trials you might be interested in
Obesity &Amp; OverweightSedentary BehaviorsCardiometabolic RiskPhysical Inactivity
This study will evaluate the effects of using a pedal-assist electric bicycle (e-bike) for commuting on physical activit…
River Falls, United StatesEst. completion Oct 31, 2027
Diabetes Mellitus, Type 2Diabetic NephropathyObesity
Background:
\- Family and twin studies have suggested that genetic factors influence approximately 50 percent of a pers…
Phoenix, United States